Allan Jonathan — SEC Form 4 filings
SEC reporting owner CIK 1966716. 24 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2024-03-19 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 36 legs across 17 filings — 132,022 shares, $2,795,971 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 40.
- Largest priced transaction: sale of 14,922 shares @ $20.14 ($300,492) in Stoke Therapeutics, Inc., filed 2025-09-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | 24 | — | 36 legs · 132,022 sh · $2,795,971 | 40 |
Form 4 filings — Allan Jonathan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 6,000 @ $0 · Sale (S): 2,716 @ $32.01 · Sale (S): 145 @ $32.47 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 1,457 @ $29.95 | EDGAR |
| 2026-03-24 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 8,692 @ $33.64 · Sale (S): 601 @ $34.41 | EDGAR |
| 2026-03-19 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 2,476 @ $32.74 · Sale (S): 1,791 @ $33.38 · Sale (S): 4,222 @ $31.28 · Sale (S): 334 @ $31.79 · Sale (S): 72 @ $32.85 | EDGAR |
| 2026-03-17 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 7,475 @ $0 · Option exercise (M): 6,000 @ $0 · Option exercise (M): 12,000 @ $0 · Option exercise (M): 7,475 (derivative) @ $0 · Option exercise (M): 6,000 (derivative) @ $0 · Option exercise (M): 12,000 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 53,000 (derivative) @ $0 · Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 1,300 @ $31.60 · Sale (S): 2,678 @ $32.61 | EDGAR |
| 2025-12-05 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 6,000 @ $0 · Sale (S): 824 @ $30.76 · Sale (S): 194 @ $31.32 · Sale (S): 1,004 @ $31.33 · Sale (S): 5,437 @ $31.08 · Sale (S): 2,344 @ $31.76 · +1 more | EDGAR |
| 2025-12-03 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 12,357 @ $0 · Sale (S): 1,416 @ $29.56 · Sale (S): 868 @ $30.14 · Sale (S): 898 @ $30.34 · Sale (S): 1,394 @ $30.85 · Option exercise (M): 12,357 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 10,000 @ $9.15 · Sale (S): 10,000 @ $25.07 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 850 @ $7.07 · Sale (S): 850 @ $20 · Option exercise (M): 9,150 @ $7.07 · Sale (S): 14,922 @ $20.14 · Sale (S): 6,345 @ $20.07 · Option exercise (M): 850 (derivative) @ $0 · +1 more | EDGAR |
| 2025-08-20 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 1,683 @ $18.24 | EDGAR |
| 2025-08-18 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 6,000 @ $0 · Grant/award (A): 12,000 (derivative) @ $0 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 13,712 @ $15 | EDGAR |
| 2025-03-20 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 2,266 @ $8.67 · Sale (S): 1,945 @ $8.27 · Grant/award (A): 72,000 (derivative) @ $0 · Grant/award (A): 48,000 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 7,475 @ $0 · Option exercise (M): 6,000 @ $0 · Option exercise (M): 7,475 (derivative) @ $0 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 12,114 @ $13.69 · Sale (S): 1,552 @ $12.99 | EDGAR |
| 2024-12-10 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 9,696 @ $12.78 | EDGAR |
| 2024-12-05 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 6,000 @ $0 · Grant/award (A): 12,000 (derivative) @ $0 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2024-12-03 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 33,927 @ $0 · Option exercise (M): 33,927 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 36,000 (derivative) @ $0 · Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 8,599 @ $7.07 · Sale (S): 8,599 @ $15.04 · Option exercise (M): 8,599 (derivative) @ $0 | EDGAR |
| 2024-04-01 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 5,026 @ $13.19 · Sale (S): 100 @ $13.81 | EDGAR |
| 2024-03-19 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 7,475 @ $0 · Sale (S): 2,349 @ $6.10 · Option exercise (M): 7,475 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1966716 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →